Toulouse, France

Justine Bertrand-Michel

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Justine Bertrand-Michel: Innovator in Pain Treatment

Introduction

Justine Bertrand-Michel is a notable inventor based in Toulouse, France. He has made significant contributions to the field of pain management through his innovative research and discoveries. His work focuses on the development of new therapeutic compounds that can alleviate pain disorders.

Latest Patents

Justine Bertrand-Michel holds a patent for "Lipopeptide compounds for the treatment of pain disorders." This invention is based on the discovery of a new bacterial compound with analgesic properties. The research highlights the potential of using a probiotic strain, Nissle 1917 (EcN), to produce amino fatty acids that exhibit analgesic effects. One of the key findings is that a specific compound can inhibit hypersensitivity to colorectal distension induced by capsaicin, a potent nociceptive agent. This compound acts via the GABA B receptor and is capable of crossing cellular epithelial barriers, such as the intestinal epithelium. The invention aims to provide a new tool for treating various pain disorders, including somatic and visceral pain.

Career Highlights

Throughout his career, Justine Bertrand-Michel has worked with esteemed institutions such as the National Institute of Health and Medical Research (Institut National De La Sante Et De La Recherche Medicale) and the University Hospital of Toulouse (Centre Hospitalier Universitaire De Toulouse). His research has been pivotal in advancing the understanding of pain mechanisms and developing innovative treatment options.

Collaborations

Justine has collaborated with notable colleagues, including Nicolas Cenac and Teresa Perez-Berezo. Their combined expertise has contributed to the success of their research endeavors and the advancement of pain management therapies.

Conclusion

Justine Bertrand-Michel's innovative work in developing lipopeptide compounds represents a significant advancement in the treatment of pain disorders. His research not only enhances our understanding of pain mechanisms but also opens new avenues for therapeutic interventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…